These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9367668)

  • 21. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation.
    Rosen CJ; Chesnut CH; Mallinak NJ
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1904-10. PubMed ID: 9177404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in the capacity of several biochemical bone markers to assess high bone turnover in early menopause and response to alendronate therapy.
    Fink E; Cormier C; Steinmetz P; Kindermans C; Le Bouc Y; Souberbielle JC
    Osteoporos Int; 2000; 11(4):295-303. PubMed ID: 10928218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis.
    Delmas PD; Schlemmer A; Gineyts E; Riis B; Christiansen C
    J Bone Miner Res; 1991 Jun; 6(6):639-44. PubMed ID: 1887826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.
    Garnero P; Hausherr E; Chapuy MC; Marcelli C; Grandjean H; Muller C; Cormier C; Bréart G; Meunier PJ; Delmas PD
    J Bone Miner Res; 1996 Oct; 11(10):1531-8. PubMed ID: 8889854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The short-term effects of conjugated estrogen on bone turnover in older women.
    Prestwood KM; Pilbeam CC; Burleson JA; Woodiel FN; Delmas PD; Deftos LJ; Raisz LG
    J Clin Endocrinol Metab; 1994 Aug; 79(2):366-71. PubMed ID: 8045949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary excretion of pyridinium cross-links in healthy women; the long-term effects of menopause and oestrogen/progesterone therapy.
    Schlemmer A; Hassager C; Delmas PD; Christiansen C
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):777-82. PubMed ID: 8033369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between urinary pyridinium cross-links and hydroxylysine glycosides in monitoring the effects of ovariectomy and 17 beta-estradiol replacement in aged rats.
    Pecile A; Netti C; Sibilia V; Villa I; Calori G; Tenni R; Coluzzi M; Moro GL; Rubinacci A
    J Endocrinol; 1996 Sep; 150(3):383-90. PubMed ID: 8882157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of D-003 (10 mg/day) on biochemical parameters of bone remodelling in postmenopausal women: a randomized, double-blind study.
    Ceballos A; Mas R; Castaño G; Fernández L; Mendoza S; Menéndez R; González JJ; Illnait J; Gámez R; Mesa M; Fernández J
    Int J Clin Pharmacol Res; 2005; 25(4):175-86. PubMed ID: 16402634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urine products of bone breakdown as markers of bone resorption and clinical usefulness of urinary hydroxyproline: an overview.
    Simsek B; Karacaer O; Karaca I
    Chin Med J (Engl); 2004 Feb; 117(2):291-5. PubMed ID: 14975218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary pyridinium cross-links as markers of bone resorption in tumor-associated hypercalcemia.
    Body JJ; Delmas PD
    J Clin Endocrinol Metab; 1992 Mar; 74(3):471-5. PubMed ID: 1740478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reference intervals of biochemical bone turnover markers for Saudi Arabian women: a cross-sectional study.
    Ardawi MS; Maimani AA; Bahksh TA; Rouzi AA; Qari MH; Raddadi RM
    Bone; 2010 Oct; 47(4):804-14. PubMed ID: 20659600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation.
    Krane SM; Kantrowitz FG; Byrne M; Pinnell SR; Singer FR
    J Clin Invest; 1977 May; 59(5):819-27. PubMed ID: 404321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
    Alvarez L; Guañabens N; Peris P; Monegal A; Bedini JL; Deulofeu R; Martinez de Osaba MJ; Muñoz-Gomez J; Rivera-Fillat F; Ballesta AM
    J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of an immunoassay for urinary galactosylhydroxylysine.
    Leigh SD; Ju HS; Lundgard R; Daniloff GY; Liu V
    J Immunol Methods; 1998 Nov; 220(1-2):169-78. PubMed ID: 9839938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
    Marcus R; Holloway L; Wells B; Greendale G; James MK; Wasilauskas C; Kelaghan J
    J Bone Miner Res; 1999 Sep; 14(9):1583-95. PubMed ID: 10469288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone sialoprotein is a specific biochemical marker of bone metabolism in postmenopausal women: a randomized 1-year study.
    Störk S; Störk C; Angerer P; Kothny W; Schmitt P; Wehr U; von Schacky C; Rambeck W
    Osteoporos Int; 2000; 11(9):790-6. PubMed ID: 11148806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
    Heikkinen AM; Parviainen M; Niskanen L; Komulainen M; Tuppurainen MT; Kröger H; Saarikoski S
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2476-82. PubMed ID: 9253321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.
    Garnero P; Gineyts E; Riou JP; Delmas PD
    J Clin Endocrinol Metab; 1994 Sep; 79(3):780-5. PubMed ID: 8077361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Markers of bone resorption--measurement in serum, plasma or urine?
    Huber F; Traber L; Roth HJ; Heckel V; Schmidt-Gayk H
    Clin Lab; 2003; 49(5-6):203-7. PubMed ID: 15285175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.